Why no comments from Sanofi who are apparently gagging for our prefills?
This is standard practice. Couldn't we even get a comment?
Combined with the deal being for a single drug, low upfront, slow ramp up, no definitive start date, apparent secrecy over details even though the drug is already in widespread use AND no definitive contract length - I have to currently say that this deal is a non event.
The next deal will be key. If it along the same lines, then I'm afraid UNS will be a 'go away now and come back in 3 years' investment.
UNS Price at posting:
58.5¢ Sentiment: Hold Disclosure: Held